✦ LIBER ✦

Plasma-exchange program in a regional blood bank with a reference to Guillain-Barré syndrome

✍ Scribed by Prakash C. Das; Cees Th. Smit Sibinga

Book ID: 105650672
Publisher: Springer
Year: 1983
Tongue: English
Weight: 444 KB
Volume: 13
Category: Article
ISSN: 0940-5437
DOI: 10.1007/bf02904747

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Plasma Exchange as a Therapy for Guillai

Plasma Exchange as a Therapy for Guillain-Barré Syndrome with Immune Complexes

✍ M. Valbonesi; S. Garelli; L. Mosconi; D. Zerbi; I. Celano 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 310 KB

Plasma Exchange as a Therapy for Guillai

Plasma Exchange as a Therapy for Guillain-Barré Syndrome with Immune Complexes

📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

Immunological Monitoring of a Patient wi

Immunological Monitoring of a Patient with Guillain-Barré Syndrome Successfully Treated with Plasma Exchange

✍ G. Fiorini; G. Bigi; M. L. Paracchini; C. Marinig; A. Gibelli 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB

A randomized trial comparing intravenous

A randomized trial comparing intravenous immunoglobulin and plasma exchange in Guillain-Barré syndrome

✍ Kleyweg, R.P.; van der Meché, F.G.A.; Schmitz, P.I.M. 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 341 KB

Pilot trial of immunoglobulin versus pla

Pilot trial of immunoglobulin versus plasma exchange in patients with Guillain-Barre syndrome

✍ Bril, V.; Ilse, W. K.; Pearce, R.; Dhanani, A.; Sutton, D.; Kong, K. 📂 Article 📅 1996 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 538 KB

The acute phase reactant, fibrinogen, as

The acute phase reactant, fibrinogen, as a guide to plasma exchange therapy for acute Guillain-Barré syndrome

✍ Rashmi Sanjay; Janice Flanagan; Donata Sodano; Kenneth C. Gorson; Allan H. Roppe 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB

The Guillian Barré syndrome is an acute inflammatory disorder for which plasma exchange is effective treatment. Up to 10% relapse after plasma exchange suggesting that treatment sometimes finishes before disease activity has resolved. We studied whether plasma fibrinogen, an inflammatory marker, mig